KaydedilenlerDerginizi ekleyin

Dergiler / Haseki Tıp Bülteni / 2021 / Cilt: 59 - Sayı: 3

Drug-Associated Thrombocytopenia as a Rare and Devastating Side Effect of Octreotide in a Cirrhotic Patients: A Case Report and Current Literature Review

Onur KESKİN
Alper Tuna GÜVEN
Sabri Engin ALTINTOP
Sayfa
265–267
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The case is reported in discussion with the existing 4 cases in theliterature.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Variceal bleeding is one of the most serious outcomes encountered in portal hypertension.
📊
Temel Bulgular & Veri:Naranjo adverse drug reactionprobability scale has revealed a probable relationship with 6 points.
💡
Sonuç & Katkı:The case is reported in discussion with the existing 4 cases in theliterature.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Variceal bleeding is one of the most serious outcomes encountered in portal hypertension. It represents one of the leading causesof death in cirrhotic patients. Octreotide infusion is the mainstay of treatment in variceal bleeding. It shows its effects by loweringportal venous pressure. Here, we present a patient with variceal bleeding who experienced sudden thrombocytopenia after octreotideinfusion. Cessation of the octreotide therapy has resulted in a quick recovery of the platelet counts. Naranjo adverse drug reactionprobability scale has revealed a probable relationship with 6 points. The case is reported in discussion with the existing 4 cases in theliterature.

🔖

Bu Makaleye Atıf Yap

KESKİN, O., GÜVEN, A. T., ALTINTOP, S. E. (2022). Drug-Associated Thrombocytopenia as a Rare and Devastating Side Effect of Octreotide in a Cirrhotic Patients: A Case Report and Current Literature Review. Haseki Tıp Bülteni, Cilt: 59 - Sayı: 3, 265–267. https://ajindex.com/articles/534978

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. D’Amico G, De Franchis R; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599-612
  2. Bañares R, Albillos A, Rincón D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002;35:609- 15
  3. Gøtzsche PC, Hróbjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev 2008;2008:CD000193
  4. Hanna WT, Maull KI. Sandostatin-induced thrombocytopenia. South Med J 1990;83:77
  5. Demirkan K, Fleckenstein JF, Self TH. Thrombocytopenia associated with octreotide. Am J Med Sci 2000;320:296-7
  6. Chisholm S, Gummadi B, Vega KJ, House J. Sandostatin causing reversible thrombocytopenia. Eur J Gastroenterol Hepatol 2009;21:474-5
  7. Rashidi A, Rizvi N. Octreotide-induced thrombocytopenia: a case report. J Med Case Rep 2011;5:286
  8. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-7
  9. Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drugdependent antibodies to platelets in quinidine- and quinineinduced thrombocytopenia. J Clin Invest 1985;75:310-4
  10. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.